UBS Group’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.2K | Sell |
|
|||||
|
2025
Q1 | $207K | Buy |
|
|||||
|
2024
Q4 | $478K | Buy |
|
|||||
|
2024
Q3 | $8.07K | Sell |
|
|||||
|
2024
Q2 | $67.2K | Sell |
|
|||||
|
2024
Q1 | $415K | Buy |
|
|||||
|
2023
Q4 | $143K | Sell |
|
|||||
|
2023
Q3 | $199K | Sell |
|
|||||
|
2023
Q2 | $739K | Sell |
|
|||||
|
2023
Q1 | $2.99M | Buy |
|
|||||
|
2022
Q4 | $2.99M | Sell |
|
|||||
|
2022
Q3 | $1.7M | Buy |
|
|||||
|
2022
Q2 | $1.54M | Sell |
|
|||||
|
2022
Q1 | $3.78M | Sell |
|
|||||
|
2021
Q4 | $4.06M | Sell |
|
|||||
|
2021
Q3 | $6.55M | Buy |
|
|||||
|
2021
Q2 | $4.67M | Sell |
|
|||||
|
2021
Q1 | $8.52M | Buy |
|
|||||
|
2020
Q4 | $4.25M | Buy |
|
|||||
|
2020
Q3 | $3.81M | Buy |
|
|||||
|
2020
Q2 | $4.29M | Sell |
|
|||||
|
2020
Q1 | $1.93M | Sell |
|
|||||
|
2019
Q4 | $1.36M | Buy |
|
|||||
|
2019
Q3 | $563K | Buy |
|
|||||
|
2019
Q2 | $828K | Buy |
|
|||||
|
2019
Q1 | $743K | Buy |
|
|||||
|
2018
Q4 | $49K | Buy |
|
|||||
|
2018
Q3 | $30K | Buy |
|
|||||
|
2018
Q2 | $29K | Buy |
|
|||||
|
2018
Q1 | $27K | Buy |
|